The safety of COX-2 inhibitors is monitored through post-marketing surveillance and ongoing clinical trials. Regulatory agencies like the FDA continuously review data to ensure that the benefits of these drugs outweigh the risks. Physicians are advised to use the lowest effective dose for the shortest duration necessary.
